Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06611982 · ClinicalTrials.gov registry record · NA

Guaranteed Income and Financial Treatment

A NA study of Cancer and Quality of Life, sponsored by Meredith Doherty, PhD, LCSW.

Active
Registry status
NA
Development phase
250
Enrollment target
3
Study locations

NCT06611982: Active NA study of Cancer and Quality of Life, sponsored by Meredith Doherty, PhD, LCSW.

NCT06611982 is a NA study of Cancer and Quality of Life that is active but no longer recruiting, run by Meredith Doherty, PhD, LCSW. The registered enrollment target is 250 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (93% lower). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT06611982, a NA study of Cancer and Quality of Life, is active but no longer recruiting, sponsored by Meredith Doherty, PhD, LCSW.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
250 participants
Enrollment target
3
Study locations

Study Summary

The goal of this clinical trial is to learn if providing advanced cancer patients with $1000/month for 12 months will improve cancer outcomes. The main questions it aims to answer are: To what extent does receiving $1000/month additional income reduce financial hardship? To what extent does receiving $1000/month additional income improve quality of life? Does receiving $1000/month additional income improve survival outcomes? Participants will: Receive $1000/month for 12 months Complete a survey every 3 months for 12 months If selected, participate in semi-structured interviews about their financial behaviors

Primary Outcome

COmprehensive Score for Financial Toxicity (COST)

Interventions

  • OTHER Unconditional cash transfer
  • OTHER Contact information for social worker and financial counselor

Study Locations (3)

Pennsylvania

  • Penn Presbyterian Medical Center - Philadelphia
  • Jefferson Health - Philadelphia

New York

  • Pennsylvania Hospital - Philadelphia

Trial Details

FieldValue
Enrollment Target 250 participants
Start Date 2023-04-01
Est. Completion 2026-07-30
Phase NA
Meredith Doherty, PhD, LCSW

1 total trials

What the registry record for NCT06611982 still lists

NCT06611982 is an interventional study that assigns participants to a tested intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (93% lower).

The record links to 3 conditions, with Cancer appearing as the primary indexed condition, and to 2 interventions - of which Unconditional cash transfer is the first listed.

NCT06611982 reports a single indexed study location in Pennsylvania, New York.

Frequently Asked Questions

What is clinical trial NCT06611982 about?

NCT06611982 is a clinical study titled "Guaranteed Income and Financial Treatment". The goal of this clinical trial is to learn if providing advanced cancer patients with $1000/month for 12 months will improve cancer outcomes. The main questions it aims to answer are: To what extent does receiving $1000/month additional income reduce financial hardship? To what extent does receivi...

What is the current status of trial NCT06611982?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2023-04-01. Estimated completion is 2026-07-30.

What conditions does trial NCT06611982 study?

This clinical trial studies the following conditions: Cancer, Quality of Life, Financial Hardship.

What interventions are being tested in trial NCT06611982?

The interventions under investigation include: Unconditional cash transfer (OTHER), Contact information for social worker and financial counselor (OTHER).

Who is sponsoring clinical trial NCT06611982?

This trial is sponsored by Meredith Doherty, PhD, LCSW, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06611982 being conducted?

This trial has 3 study locations across New York, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06611982's enrollment target sits among peer trials

250 205th of 615 higher than 408 of 615 other Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00483249 · 250 participants · NA

    Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm

  • NCT00777712 · 250 participants

    Mechanisms Underlying Impaired Diabetic Wound Healing

  • NCT01451502 · 250 participants · NA

    Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units

  • NCT01771718 · 250 participants

    Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06611982, the US trial registry maintained by the National Library of Medicine. NCT06611982 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.